Arlington Partners’s Qiagen QGEN Stock Holding History

Arlington Partners’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-106	Closed	-$6K	–	612
2021 Q4	$6K	Buy	+106	New	+$6.08K	﹤0.01%	554

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Arlington Partners's QGEN Position: Q1 2022 in Review

Arlington Partners sold out of Qiagen (QGEN) in Q1 2022, closing a stake of 106 shares — an estimated $6K sold.

Arlington Partners first reported a position in QGEN in Q4 2021 and held it in 1 quarter. The position peaked at $6K in Q4 2021. 292 funds tracked by Wall St. Rank hold QGEN as of Q1 2022.

Arlington Partners reported no remaining Qiagen position as of Q1 2022 after selling out during the quarter.
Arlington Partners sold 106 Qiagen shares in Q1 2022, an estimated $6K.
Arlington Partners first reported a position in Qiagen in Q4 2021 and held it in 1 quarter.
Arlington Partners's Qiagen position peaked at $6K in Q4 2021.
292 funds tracked by Wall St. Rank held Qiagen as of Q1 2022.

Based on Arlington Partners's 13F filing for Q1 2022, filed 14 Apr 2022.